Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gesine Bug

Showing results (31-40 of 165) with videos related to

Pageof 17
Sort By:
Frontiers in Immunology|December 3, 2024
GVHD after CAR T-cell therapy post allogeneic hematopoietic cell transplantation - successfully treated by extracorporeal photopheresisKiavasch Mohammad Nejad Farid, Gesine Bug, Anita Schmitt, et al.
Annals of Hematology|April 9, 2016
Mismatched unrelated hematopoietic stem cell transplantation with post-transplant cyclophosphamide for high-risk acute myeloid leukemiaSarah Lindner, Tobias Berg, Julia Riemann, et al.
Cytotherapy|March 4, 2014
Immunomagnetic selection or irradiation eliminates alloreactive cells but also reduces anti-tumor potential of cytokine-induced killer cells: implications for unmanipulated cytokine-induced killer cell infusionEva Rettinger, Hermann Kreyenberg, Michael Merker, et al.
Annals of Hematology|August 8, 2023
Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AMLAnjali Cremer, Julius C Enssle, Saskia Pfaff, et al.
Molecular Cancer Therapeutics|September 4, 2012
Breakdown of the FLT3-ITD/STAT5 axis and synergistic apoptosis induction by the histone deacetylase inhibitor panobinostat and FLT3-specific inhibitorsKristin Pietschmann, Hella Anna Bolck, Marc Buchwald, et al.
Cancer Research|April 5, 2005
Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cellsGesine Bug, Hilal Gül, Kerstin Schwarz, et al.
Infection|December 19, 2024
Risk factors and outcome of Pseudomonas aeruginosa bloodstream infections (PABSI) in hematological patients: a single center retrospective cohort studyJohanna Kessel, Gesine Bug, Björn Steffen, et al.
Cancers|September 29, 2019
HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1Mandy Beyer, Annette Romanski, Al-Hassan M Mustafa, et al.
Genes & Cancer|January 9, 2015
STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AMLClaudia Oancea, Brigitte Rüster, Boris Brill, et al.
Clinical Epigenetics|June 19, 2012
Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acidAndrea Kuendgen, Gesine Bug, Oliver G Ottmann, et al.
Pageof 17

Showing results (31-40 of 165) with videos related to

Sort By:
Pageof 17
Frontiers in Immunology|December 3, 2024
GVHD after CAR T-cell therapy post allogeneic hematopoietic cell transplantation - successfully treated by extracorporeal photopheresisKiavasch Mohammad Nejad Farid, Gesine Bug, Anita Schmitt, et al.
Annals of Hematology|April 9, 2016
Mismatched unrelated hematopoietic stem cell transplantation with post-transplant cyclophosphamide for high-risk acute myeloid leukemiaSarah Lindner, Tobias Berg, Julia Riemann, et al.
Cytotherapy|March 4, 2014
Immunomagnetic selection or irradiation eliminates alloreactive cells but also reduces anti-tumor potential of cytokine-induced killer cells: implications for unmanipulated cytokine-induced killer cell infusionEva Rettinger, Hermann Kreyenberg, Michael Merker, et al.
Annals of Hematology|August 8, 2023
Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AMLAnjali Cremer, Julius C Enssle, Saskia Pfaff, et al.
Molecular Cancer Therapeutics|September 4, 2012
Breakdown of the FLT3-ITD/STAT5 axis and synergistic apoptosis induction by the histone deacetylase inhibitor panobinostat and FLT3-specific inhibitorsKristin Pietschmann, Hella Anna Bolck, Marc Buchwald, et al.
Cancer Research|April 5, 2005
Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cellsGesine Bug, Hilal Gül, Kerstin Schwarz, et al.
Infection|December 19, 2024
Risk factors and outcome of Pseudomonas aeruginosa bloodstream infections (PABSI) in hematological patients: a single center retrospective cohort studyJohanna Kessel, Gesine Bug, Björn Steffen, et al.
Cancers|September 29, 2019
HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1Mandy Beyer, Annette Romanski, Al-Hassan M Mustafa, et al.
Genes & Cancer|January 9, 2015
STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AMLClaudia Oancea, Brigitte Rüster, Boris Brill, et al.
Clinical Epigenetics|June 19, 2012
Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acidAndrea Kuendgen, Gesine Bug, Oliver G Ottmann, et al.
Pageof 17